Beta-Thalassemia Recruiting Phase 2 Trials for Luspatercept (DB12281)

Also known as: Beta-thalassemia / Thalassemia beta / Beta thalassemia / Beta thalassaemia / Beta thalassemia major / Thalassaemia beta / Beta-thalassaemia

IndicationStatusPhase
DBCOND0027982 (Beta-Thalassemia)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04143724Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Subjects Who Require Regular RBC Transfusions Due to Beta (β)-Thalassemia.Treatment